Express Pharma

OCTOBER 16, 2024

The CRO sector in India, growing at a compound annual growth rate (CAGR) of 10.75 Similarly, India’s pharmaceutical contract manufacturing market is expected to increase at a CAGR of 14.67 per cent, is projected to reach $2.5 billion by 2030 (2). per cent, hitting $44.63 billion by 2029 (3).

Biosimilars 103

Biosimilars Compounding Pharmaceutical Companies Pharmaceutical Companies 103

Pharmaceutical Technology

OCTOBER 31, 2022

billion in 2031, at a compound annual growth rate (CAGR) of 4.4%. Two categories of novel therapies stand out: cell therapies and therapies with novel MOAs, with new products in each category being forecast to launch between 2023 and 2025. The osteoarthritis (OA) market was valued at $2.5 of the 7MM sales, respectively.

Compounding 59

Compounding Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

JANUARY 10, 2023

Approximately 30% of global data volume is generated by the healthcare industry and it will continue to expand with a compound annual growth rate predicted to reach 36% by 2025, according to research by RBC Capital Markets. Capturing market share.

Compounding 98

Compounding Communication Pharmaceutical Companies Pharmaceutical Companies 98

The Thyroid Pharmacist

NOVEMBER 29, 2023

The truth is that most supplement companies do not undergo the same scrutiny and testing that pharmaceutical products do, because many of the tests which are required of pharmaceutical companies are voluntary for supplement companies. We have 270 expiring in March 2025.) We have 299 expiring in March 2025.)

Health and Personal Care Stores 73

Health and Personal Care Stores Immunity Immunization Labelling 73

Pharmaceutical Technology

MARCH 22, 2023

Large-molecule drugs such as biologics are particularly sensitive to foreign contamination and E&L interaction, making these issues key concerns for pharmaceutical companies. From 2025, it will be substituted with a new chapter on functional tests for the complete system.”

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 19, 2023

Pharmaceutical companies are putting their trust in the immense potential this new generation of medicine has for treating individuals with rare genetic diseases, which currently affect an estimated 280 million patients worldwide.

Packaging 52

Packaging Compounding Communication Pharmaceutical Companies 52

Viseven

AUGUST 29, 2024

Although 5G is currently limited to large cities in developed countries, by around 2025, we can expect its reach will extend beyond the urban areas. Pharmaceutical companies Pharmaceutical companies can transform their approaches to clinical trials with the help of 5G networks.

Communication 52

Communication Hospitals Pharmaceutical Companies Pharmaceutical Companies 52